Endogenous Regulators of Adult CNS Neurogenesis
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1829-1840
Author(s):
Theo Hagg
Neurotrophic Factors in Combination: A Possible new Therapeutic Strategy to Influence Pathophysiology of Spinal Cord Injury and Repair Mechanisms
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1841-1874
Author(s):
Hari Shanker Sharma
Drugs of Abuse-Induced Hyperthermia, Blood-Brain Barrier Dysfunction and Neurotoxicity: Neuroprotective Effects of a New Antioxidant Compound H-290/51
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1903-1923
Author(s):
Hari Shanker Sharma, Per-Ove Sjoquist and Syed F. Ali
Current Experimental Therapy for Alzheimers Disease
Journal:
Current Neuropharmacology
Volume:
5
Page:
127-134
Author(s):
Sheng Chen, Xiao-Jie Zhang, Liang Li and Wei-Dong Le
Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
175-186
Author(s):
Constantinos Mikelis, Marina Koutsioumpa and Evangelia Papadimitriou
Patent Selections
Journal:
Recent Patents on CNS Drug Discovery (Discontinued)
Volume:
2
Page:
167-172
Author(s):
Bentham Science Publishers
Therapeutic Potential of Metabotropic GABA (GABAB) Receptors and their Effector Ion Channels
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
7
Page:
129-144
Author(s):
Rafael Lujan
Glycosphingolipid Structure and Function in Membranes
Journal:
Current Organic Chemistry
Volume:
11
Page:
579-589
Author(s):
Annika Wedeking and Gerhild van Echten-Deckert
Pathologically-Activated Therapeutics for Neuroprotection: Mechanism of NMDA Receptor Block by Memantine and S-Nitrosylation
Journal:
Current Drug Targets
Volume:
8
Page:
621-632
Author(s):
Stuart A. Lipton
Will Medicinal Cannabinoids Prove to be Useful Clinically?
Journal:
Current Drug Therapy
Volume:
2
Page:
143-150
Author(s):
Paul F. Smith